Posted On: 08/12/2015 8:34:06 AM
Post# of 72446
Dana Farber is onboard, Kevetrin is surpassing expectations so far imo. This will gain even more visibility once we see top line data imo.
20 Jan 2015
Additionally, the Principal Investigators for the Kevetrin trial have requested that the Company start preparing a presentation to be used for an article on the safety and pharmacological effect of Kevetrin on multiple cancer lines as demonstrated in the clinical trial. Cellceutix interprets this recommendation as a very optimistic sign regarding anticipated outcomes for the trial and clinical advancement of Kevetrin. - See more at: http://cellceutix.com/cellceutix-reports-sple...Ylj1G.dpuf
http://cellceutix.com/cellceutix-reports-sple...Ylj1G.dpbs
http://cellceutix.com/wp-content/uploads/2014...umors..pdf
Ready to knock shorty out of the park. Picking up every penny out in the parking lot even.
20 Jan 2015
Additionally, the Principal Investigators for the Kevetrin trial have requested that the Company start preparing a presentation to be used for an article on the safety and pharmacological effect of Kevetrin on multiple cancer lines as demonstrated in the clinical trial. Cellceutix interprets this recommendation as a very optimistic sign regarding anticipated outcomes for the trial and clinical advancement of Kevetrin. - See more at: http://cellceutix.com/cellceutix-reports-sple...Ylj1G.dpuf
http://cellceutix.com/cellceutix-reports-sple...Ylj1G.dpbs
http://cellceutix.com/wp-content/uploads/2014...umors..pdf
Ready to knock shorty out of the park. Picking up every penny out in the parking lot even.
(0)
(0)
